Robert Iannone
Technik-/Wissenschafts-/F&E-Leiter bei JAZZ PHARMACEUTICALS PLC
Vermögen: 7 Mio $ am 30.04.2024
Aktive Positionen von Robert Iannone
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| JAZZ PHARMACEUTICALS PLC | Technik-/Wissenschafts-/F&E-Leiter | 29.05.2019 | - |
| ITEOS THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 03.05.2021 | - |
| Independent Dir/Board Member | 03.05.2021 | - | |
| AUTOLUS THERAPEUTICS PLC | Direktor/Vorstandsmitglied | 20.06.2023 | - |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2019 | - |
Karriereverlauf von Robert Iannone
Ehemalige bekannte Positionen von Robert Iannone
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| JOUNCE THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 21.01.2020 | 03.05.2023 |
| Independent Dir/Board Member | 21.01.2020 | 03.05.2023 | |
| IMMUNOMEDICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 09.04.2018 | 28.05.2019 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01.07.2014 | 01.04.2018 |
| MERCK & CO., INC. | Direktor/Vorstandsmitglied | 01.03.2008 | 01.07.2014 |
| Corporate Officer/Principal | 01.03.2008 | 01.07.2014 | |
| University of Pennsylvania Medical Center | Corporate Officer/Principal | 01.01.2001 | 01.01.2012 |
Ausbildung von Robert Iannone
| University of Pennsylvania Medical Center | Graduate Degree |
| The Catholic University of America | Undergraduate Degree |
| Yale University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 9 |
| Vereinigtes Königreich | 3 |
| Irland | 2 |
Operativ
| Director/Board Member | 4 |
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 3 |
Sektoral
| Health Technology | 8 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| JAZZ PHARMACEUTICALS PLC | Health Technology |
| MERCK & CO., INC. | Health Technology |
| ITEOS THERAPEUTICS, INC. | Health Technology |
| AUTOLUS THERAPEUTICS PLC | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ. | Health Technology |
Jounce Therapeutics, Inc.
 Jounce Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which engages in developing treatments for cancer. It also provides novel cancer immunotherapies to attack tumors. The company was founded by Louis M. Weiner, Drew M. Pardoll, Thomas F. Gajewski, James P. Allison, Robert Schreiber, and Padmanee Sharma in 2013 and is headquartered in Cambridge, MA. | Commercial Services |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Health Technology |
- Börse
- Insiders
- Robert Iannone
- Erfahrung
